Orozco Johnnie J, Carter Joseph J, Koutsky Laura A, Galloway Denise A
Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
J Virol. 2005 Aug;79(15):9503-14. doi: 10.1128/JVI.79.15.9503-9514.2005.
Although epitope mapping has identified residues on the human papillomavirus (HPV) major capsid protein (L1) that are important for binding mouse monoclonal antibodies, epitopes recognized by human antibodies are not known. To map epitopes on HPV type 6 (HPV6) L1, surface-exposed loops were mutated to the corresponding sequence of HPV11 L1. HPV6 L1 capsomers had one to six regions mutated, including the BC, DE, EF, FG, and HI loops and the 139 C-terminal residues. After verifying proper conformation, hybrid capsomers were used in enzyme-linked immunosorbent assays with 36 HPV6-seropositive sera from women enrolled in a study of incident HPV infection. Twelve sera were HPV6 specific, while the remainder reacted with both HPV6 and HPV11 L1. By preadsorption studies, 6/11 of these sera were shown to be cross-reactive. Among the HPV6-specific sera there was no immunodominant epitope recognized by all sera. Six of the 12 sera recognized epitopes that contained residues from combinations of the BC, DE, and FG loops, one serum recognized an epitope that consisted partially of the C-terminal arm, and three sera recognized complex epitopes to which reactivity was eliminated by switching all five loops. Reactivity in two sera was not eliminated even with all six regions swapped. The patterns of epitope recognition did not change over time in women whose sera were examined 9 years after their first-seropositive visit.
尽管表位作图已确定人乳头瘤病毒(HPV)主要衣壳蛋白(L1)上对结合小鼠单克隆抗体很重要的残基,但人抗体识别的表位尚不清楚。为了绘制6型HPV(HPV6)L1上的表位,将表面暴露的环突突变为HPV11 L1的相应序列。HPV6 L1衣壳粒有1至6个区域发生突变,包括BC环、DE环、EF环、FG环、HI环以及139个C末端残基。在验证了正确的构象后,将杂交衣壳粒用于酶联免疫吸附试验,该试验使用了来自一项HPV新发感染研究中36名HPV6血清反应阳性女性的血清。12份血清是HPV6特异性的,其余血清与HPV6和HPV11 L1均有反应。通过预吸附研究,这些血清中有6/11显示为交叉反应性。在HPV6特异性血清中,没有所有血清都识别的免疫显性表位。12份血清中有六份识别包含BC环、DE环和FG环组合残基的表位,一份血清识别部分由C末端臂组成的表位,三份血清识别通过切换所有五个环突可消除反应性的复合表位。即使所有六个区域都进行了交换,两份血清中的反应性也未消除。在首次血清反应阳性就诊9年后对其血清进行检测的女性中,表位识别模式未随时间变化。